D-1257-2020 Class I Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- May 6, 2020
- Initiation Date
- April 18, 2020
- Termination Date
- October 21, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 22,488 Duplex containers
Product Description
Ceftazidime for Injection USP and Dextrose for Injection USP, 2 g, 50 mL Duplex Container, RX only, B Braun Medical Inc., Bethlehem, PA 18018-3524, NDC 0264-3145-11
Reason for Recall
Failed Stability Specifications: Out-of-Specification (OOS) results for High Molecular Weight Polymers.
Distribution Pattern
Product was distributed nationwide within the United States.
Code Information
Lot #: H8J812, Exp. Date 31 JUL 2020